The spread of antibiotic-resistant bacteria and resistance genes in clinical settings and veterinary fields is a global public health concern \[[@r23]\]. Therefore, the WHO recommends the monitoring of antibiotic resistance in each country \[[@r25]\]. In response to this recommendation, the trend in antibiotic resistance in Japanese livestock has been continually monitored since 1999, and this system is known as the Japanese Veterinary Antimicrobial Resistance Monitoring System (JVARM) \[[@r16]\].

On the other hand, the prevalence of antibiotic-resistant bacteria and resistance genes in companion animals has not been monitored in Japan, and several local and intermittent studies have been reported \[[@r7], [@r18]\]. In 2016, the government of Japan proposed the "National Action Plan on Antimicrobial Resistance 2016--2020" to address these antimicrobial problems. The importance of antimicrobial surveillance in veterinary fields is also documented from the view of One-Health approach in that plan.

Aminoglycosides are used for severe bacterial infectious diseases in both clinical settings and veterinary fields \[[@r13]\], and emergence of aminoglycoside-resistant bacteria is problematic. In Japan, the amounts of aminoglycosides usage were lower than those of some antibiotics in livestock and companion animals \[[@r17]\]. In aminoglycosides, streptomycin is relatively used in pigs and streptomycin resistance in *E. coli* are highly isolated from pigs \[[@r16], [@r17]\]. Most aminoglycosides bind to the decoding aminoacyl-tRNA recognition site of the 16S rRNA that is part of the bacterial 30S ribosome, and subsequently interfere with bacterial growth through inhibition of protein synthesis \[[@r15]\]. Bacteria acquire resistance against aminoglycosides through several mechanisms. Aminoglycoside-modifying enzymes \[aminoglycoside acetyltransferase (AAC), aminoglycoside phosphotransferase (APH), and aminoglycoside nucleotidyltranferases (ANT)\], which inactivate specific aminoglycosides, are the most prevalent mechanisms \[[@r21]\]. In addition, 16S rRNA methylases has been reported as a novel aminoglycoside resistance mechanism \[[@r24]\]. Differently from aminoglycoside-modifying enzymes, 16S rRNA methylases can confer high-level aminoglycoside resistance by modifying specific nucleotides in the aminoglycoside binding site of 16S rRNA \[[@r24]\].

In general, 16S rRNA methylases genes are located in transferable plasmids \[[@r24]\]. In addition, 16S rRNA methylases-harboring plasmids frequently contain other classes of antibiotic resistance genes such as β-lactamase genes \[[@r24]\]. Therefore, these observations warn the increase of multi-drug resistant bacteria by an acquisition of 16S rRNA methylase-harboring plasmid. Although 16S rRNA methylases possessing Gram-negative bacteria has been found in livestock and companion animals in foreign countries \[[@r5], [@r24], [@r27]\], the isolation and prevalence have not been reported in Japanese animals. In this study, we investigated the prevalence of 16S rRNA methylase genes in Gram-negative bacteria isolated from companion animals and livestock in Japan.

A total of 212 and 234 *Escherichia coli* isolated from feces samples of dogs that_visited 13 veterinary hospitals (all these hospitals are located in Ebetsu city, Japan) in 2005 and 2015--2016, respectively. A total of 1,029 and 1,418 *E. coli* isolates derived from livestock (cattle, pigs, and chicken feces) were collected by the JVARM in 2004--2005 and 2013--2014, respectively \[[@r16]\]. In addition, a total of 103 *Klebsiella* spp. \[[@r9]\], 60 *Enterobacter* spp. \[[@r8]\], and 81 *Acinetobacter* spp. isolates, obtained from clinical specimens collected from dogs and cats between 2003 and 2015, were used for this study. Bacterial identification was conducted using matrix-assisted laser desorption/ionization---time of light mass spectrometry (MALDI-TOF MS) with the Bruker MALDI Biotyper system (Bruker Daltonics, Bremen, Germany) \[[@r3]\].

To screen aminoglycoside-resistant isolates, minimum inhibitory concentrations (MICs) of gentamicin (Sigma-Aldrich, St. Louis, MO, U.S.A.) were determined using the agar dilution method according to Clinical Laboratory Standards Institute (CLSI) guidelines \[[@r2], [@r24]\]. *E. coli* ATCC25922, *Staphylococcus aureus* ATCC29213, *Enterococcus faecalis* ATCC29212, and *Pseudomonas aeruginosa* ATCC27853 were used as quality control strains. In gentamicin-resistant isolates, MICs of several types of aminoglycosides \[amikacin, neomycin, and apramycin (all obtained from Sigma-Aldrich)\] were determined to screen putative 16S rRNA methylase positive isolates according to a previous study \[[@r24]\]. Interpretations for neomycin and apramycin resistance were defined according to a previous report \[[@r10]\], because of the no definition in CLSI guidelines. MIC of arbekacin (Sigma-Aldrich), which is not modified by most aminoglycoside-modifying enzymes, was also determined in the putative 16S rRNA methylase positive isolates \[[@r4]\]. The breakpoint for arbekacin was similar to that for amikacin as defined by CLSI guidelines (≥32 *µ*g/m*l*) \[[@r2]\].

Some *E. coli* isolates derived from canine feces were resistant to gentamicin (MIC ≥16 *µ*g/m*l*; 15.6 and 29.5% in 2005 and 2015--2016, respectively; [Table 1](#tbl_001){ref-type="table"}Table 1.Prevalence of gentamicin-resistant bacteria and 16S rRNA methylases genes in Japanese animalsOriginBacterial speciesYearnGentamicin resistance^a)^16S rRNA methylasesCanine fecal samples*Escherichia coli*200521233 (15.6%)*rmtB* 2 (0.9%)*E. coli*2015--201623469 (29.5%)0Cattle, Pig, Chicken fecal samples*E. coli*2004--20051,02920 (1.9%)0*E. coli*2013--20141,41814 (1.0%)0Canine, Feline clinical specimens*Klebsiella* spp.2003--201510332 (31.1%)*armA* 1 (1.0%)*Enterobacter* spp.2003--20156517 (26.2%)0*Acinetobacter* spp.2003--2015815 (6.2%)0a) Gentamicin resistance indicates a minimum inhibitory concentration ≥16 *µ*g/m*l*.). In contrast, *E. coli* isolates derived from livestock feces were rarely resistant to gentamicin (1.9 and 1.0% in 2004--2005 and 2013--2014, respectively; [Table 1](#tbl_001){ref-type="table"}). Gentamicin-resistant *Klebsiella*, *Enterobacter*, and *Acinetobacter* spp. isolates derived from companion animals in 2003--2015 were 31.1, 26.2, and 6.2% of the total, respectively ([Table 1](#tbl_001){ref-type="table"}). From the MIC values of aminoglycosides, three putative 16S rRNA methylases-positive isolates were found in two *E. coli* isolates (RGU-60 and RGU-78) and one *Klebsiella pneumoniae* isolate (KL39) ([Table 2](#tbl_002){ref-type="table"}Table 2.Characterization of 16S rRNA methylases-positive isolates from dogs and their transconjugantsStrain nameBacterial speciesYearMIC (*µ*g/m*l*)^a)^Antibiotic resistance genesGM(16)^b)^AMK(64)^b)^NEO(32)^c)^APR(64)^c)^ABK(32)^d)^SM(64)^c)^ABPC(32)^b)^TET(16)^b)^16S rRNA methylasesAminoglycoside-modifying enzymeBeta-lactamase genesTetracycline resistance gene16S rRNA methylase-positive isolatesRGU-60*Escherichia coli*2005**\>256\>256\>256**16**\>128\>128\>12864***rmtBaphA1, strA, strBbla*~TEM~*tetA*RGU-78*E. coli*2005**\>256\>256**816**\>128\>128\>128**1*rmtBstrA, strBbla*~TEM~KL39*Klebsiella pneumoniae*2015**\>256\>256256**8**\>12864\>128512***armAaphA1, strA, strBbla*~TEM~, *bla*~SHV~, *bla*~DHA~*tetA*RecipientDH5α*E. coli*0.250.52110.2522TransconjugantsTC-RGU-60--1**\>256\>256**11**\>128\>128\>128**1*rmtBstrA, strBbla*~TEM~TC-RGU-60--2**\>256\>256\>256**16**\>128\>128\>12864***rmtBaphA1, strA, strBbla*~TEM~*tetA*TC-RGU-60--3**\>256\>256\>256**16**\>128\>128\>128**2*rmtBaphA1, strA, strBbla*~TEM~TC-RGU-78--1**\>256\>256**11**\>128\>128\>128**1*rmtBstrA, strB*a) Values in parentheses indicate breakpoints. Bold type indicates resistance to individual antibiotics. b) Clinical Laboratory Standards Institute (CLSI) breakpoints \[[@r2]\]. c) Previously reported breakpoints \[[@r10]\]. d) Reference from CLSI breakpoints for amikacin. ABK; arbekacin, ABPC; ampicillin, AMK; amikacin, APR; apramycin, GM; gentamicin, MIC; minimum inhibitory concentration, NEO; neomycin, SM; streptomycin, TET; tetracycline.). In contrast, none of the putative 16S rRNA methylase positive isolates were found in *Enterobacter* or *Acinetobacter* spp. derived from companion animals.

Three of the putative 16S rRNA methylases-positive isolates were screened for 16S rRNA methylases genes (i.e., *armA*, *rmtA*, *rmtB*, *rmtC*, *rmtD*, *rmtE*, and *npmA*) using PCR and DNA sequencing \[[@r4], [@r6], [@r29]\]. The *rmtB* gene was found in two *E. coli* isolates from dogs in 2005 (0.9% of total isolates in 2005 and 0.5% of *E. coli* isolates from canine feces), and *armA* gene was found in one *K. pneumoniae* isolate (1.0%) derived from canine feces in 2015 ([Tables 1](#tbl_001){ref-type="table"} and[2](#tbl_002){ref-type="table"}).

MICs of streptomycin, ampicillin, and tetracycline (all obtained from Sigma-Aldrich) were determined as described above. Each isolate was evaluated for the presence of genes for aminoglycoside-modifying enzymes (*aadA1*, *aac(3)*, *aadB*, *aphA1*, *aphA2*, *strA*, *strB*, and *aac(6')-Ib-cr*) \[[@r14], [@r19]\], β-lactamases (*bla*~IEM~, *bla*~SHV~, *bla*~CMY-2~, *bla*~ctx-M~, and *bla*~DHA~) \[[@r12], [@r20], [@r28]\], and tetracycline resistance (*tetA, tetB, tetC, tetD, tetE,* and *tetG*) \[[@r11]\] using PCR.

Isolates RGU-60 and KL39 were resistant to neomycin and possessed the aminoglycoside phosphotransferase gene *aphA1*, which is related to neomycin (fradiomycin) and kanamycin resistance ([Table 2](#tbl_002){ref-type="table"}). All three 16S rRNA methylases-positive isolates were resistant to streptomycin and possessed the aminoglycoside phosphotransferase genes, *strA* and *strB*, which are related to streptomycin resistance. All three 16S rRNA methylases positive isolates were resistant to ampicillin and possessed the *bla*~TEM~ gene ([Table 2](#tbl_002){ref-type="table"}). In addition, isolate KL 39 possessed the β-lactamase genes *bla*~SHV~ and *bla*~DHA~, and isolates RGU-60 and KL39 were resistant to tetracycline and possessed the *tetA* gene.

Transferability of 16S rRNA methylases genes in *E. coli* was determined using previously described broth-mating methods, with slight modifications \[[@r22]\]. Briefly, the recipients were rifampicin-resistant *E. coli* K12 DH5α strain and mating was conducted at 37°C. Transconjugants were selected on Mueller-Hinton agar supplemented with 50 *µ*g/m*l* rifampicin (Sigma-Aldrich) and 4 *µ*g/m*l* gentamicin. Broth-mating methods were repeated three times. Some transconjugants were randomly selected and characterized by MIC determination of tested antibiotics and possession of antibiotic resistance genes.

The *rmtB* genes were transferred from isolates RGU-60 and RGU-78 to the recipient strain using the broth mating method, with transfer frequencies of 1.7 × 10^−5^ and 2.4 × 10^−3^, respectively ([Table 2](#tbl_002){ref-type="table"}). All transconjugants were resistant to gentamicin, amikacin, arbekacin, streptomycin, and ampicillin ([Table 2](#tbl_002){ref-type="table"}) and possessed the *rmtB*, *strA*, *strB*, and *bla*~TEM~ genes. Some transconjugants from an isolate, RGU-60, as donor were susceptible to neomycin, apramycin, and tetracycline. In these transconjugants, some resistance genes (*aphA1* and *tetA*) were not transferred together with *rmtB* genes.

In this study, the prevalence of gentamicin resistance in *E. coli* isolates from Japanese livestock was found to be low (\<2.0%), and no 16S rRNA methylases genes were found in these isolates. In China, amikacin-resistant *E. coli* and 16S rRNA methylases genes (*rmtB*, *armA*, and *rmtE*) were observed in 19.7 and 18.5% of isolates derived from livestock, respectively \[[@r27]\]. In general, usage of veterinary antibiotics appears to contribute to the appearance of antibiotic resistance in *E. coli* isolates from healthy livestock \[[@r1]\]. In addition, an increase in prevalence of 16S rRNA methylases genes is attributed to use of amikacin and/or arbekacin \[[@r24]\]. These antibiotics are used as growth promoters in livestock in China \[[@r27]\] but not in Japan. Therefore, these observations may explain the low prevalence of gentamicin-resistant *E. coli* in livestock in Japan.

Our results showed the higher prevalence of gentamicin-resistant Gram-negative bacteria in companion animals than in livestock. Although the total amount of aminoglycosides usage in companion animals were not higher than those of the other antibiotics in companion animals, the amount of gentamicin usage were more than half in aminoglycosides \[[@r17]\]. Gentamicin are frequently used for companion animals mainly as external medicine (Personal communication). External usage of antibiotics would affect the antibiotic resistance in Enterobacteriaceae, although the direct verification has not been reported. The high rates of gentamicin resistance in companion animals would be related to the usage of gentamicin in companion animals.

16S rRNA methylases-positive strains were resistant to not only aminoglycosides but also to other classes of antibiotics, and *rmtB* genes were easily transferred to other *E. coli* strains. In addition, some resistance genes (*strA, strB*, and *bla*~TEM~) were invariably transferred with 16S rRNA methylases genes. In general, 16S rRNA methylases genes are present in plasmids with other antibiotic resistance genes \[[@r24]\]. Although more detailed analyses are needed to characterize the 16S rRNA methylases-harboring plasmid found in this study, these plasmids contribute to multi-drug resistance.

Two types of 16S rRNA methylases genes were detected in companion animals, which are in close contact with humans. It indicates the possibility of the transmission of 16S rRNA methylase gene possessed bacteria and/or the harboring plasmids between human and companion animals, at relatively easy. According to the previous study, the sporadic spread of a specific *K. pneumoniae* lineage that possessed *rmtB* has been reported from companion animals, and this lineage (ST37) is also isolated form clinical setting in China \[[@r26]\]. This observation may support the possibility. On the contrast, the prevalence of 16S rRNA methylase genes in companion animals in this study was lower compared with the neighbor country, China, corresponding with the low prevalence of 16S rRNA methylase genes in human clinical settings in Japan \[[@r24]\]. Thus, current risk of the transmission of 16S rRNA methylase gene between human and companion animals should be estimated low in Japan. However, it should be required the continuous monitoring from the view of multidrug resistance of the isolated 16S rRNA methylase positive bacteria and the co-transferable aspect with other antimicrobial resistance.
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